Louis Chen
Stock Analyst at Scotiabank
(0.09)
# 4,483
Out of 5,124 analysts
10
Total ratings
20%
Success rate
-47.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Louis Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Initiates: Sector Outperform | $140 | $152.50 | -8.20% | 1 | Nov 13, 2025 | |
| CATX Perspective Therapeutics | Reiterates: Overweight | n/a | $4.71 | - | 8 | Sep 10, 2024 | |
| PCVX Vaxcyte | Reiterates: Overweight | $55 | $56.15 | -2.05% | 1 | Feb 24, 2022 |
Gilead Sciences
Nov 13, 2025
Initiates: Sector Outperform
Price Target: $140
Current: $152.50
Upside: -8.20%
Perspective Therapeutics
Sep 10, 2024
Reiterates: Overweight
Price Target: n/a
Current: $4.71
Upside: -
Vaxcyte
Feb 24, 2022
Reiterates: Overweight
Price Target: $55
Current: $56.15
Upside: -2.05%